Expert Q&A: Lessons Learned from a Total Laboratory Automation Project
Clinical Microbiology division head Jeff Fuller, FCCM, discusses his clinical laboratory’s recent automation transformation and offers tips to ensure success
Clinical Microbiology division head Jeff Fuller, FCCM, discusses his clinical laboratory’s recent automation transformation and offers tips to ensure success
For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
Inhalers and sensors that offer digital monitoring are beginning to gain FDA approval, and could solve usage issues of traditional products.
New research led by the American Cancer Society shows decreases in cervical and breast cancer screening during the pandemic.
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.